Valuation (79%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 22.94 | N/A |
| PEG Ratio (TTM) | -0.49 | N/A |
| P/S Ratio (TTM) | 1.28 | N/A |
| P/B Ratio (TTM) | 0.85 | N/A |
| P/FCF Ratio (TTM) | 14.05 | N/A |
| Price to 5YR AVG Earnings Ratio | 9.64 | N/A |
| Price to 5YR AVG FCF Ratio | 9.44 | N/A |
Profitability (25%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 1.43% | N/A |
| ROE (TTM) | 3.70% | N/A |
| Net Profit Margin (TTM) | 5.51% | N/A |
| ROIC 5YR AVG | 8.77% | N/A |
Growth (60%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -46.23% | 21.16% | -3.63% |
| Revenue | 2.78% | 15.33% | 9.77% |
| Net Income | -43.53% | 22.19% | -2.49% |
| Cash Flow | 83.02% | 161.90% | 85.84% |
Health (58%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 3.24 | N/A |
| Quick Ratio (TTM) | 3.24 | N/A |
| D/E Ratio (TTM) | 0.97 | N/A |
| Interest Coverage (TTM) | 9.46 | N/A |
| Piotroski F-Score | 6 | N/A |
| Altman Z-Score | 1.37 | N/A |
| LTL to 5YR AVG FCF | 0.84 | N/A |
| Shares Outstanding Growth 5YR AVG | 0.25% | N/A |